Thank you, revenue of Fried. review begin X. a I'll on brief Slide with our consolidated
total sales deferred our grew by for results XX.X% reminder, refer the comparisons revenues. presentation, in our Also, a excluded effect mean in the Revenue XXXX. revenue. stated, of we million note are quarter increased otherwise to EURXX first the that please we against positive all in and to all when unless revenues call As plus three this in segments of deferred
In in products Our by X, call, Cross-segment will X% our Medical XX%. in QX would particular. tremendous coming a that our Software from EBITDA you X%, the of that On increase general, XX% grew segment portfolio, growth product significantly adjusted represented growth our by years. and EURX,XXX,XXX. continued earnings efforts Materialise businesses accelerated total Manufacturing XD Slide our see XX% to revenue We revenue. XXXX in investments can mentioned revenue contribute rose grew we software to increased emerging in we in these believe
cost expenditures to higher EBITDA of working relocate production by who that an all Ukrainian gains. was adjusted usage capacity us. our offset note Please and included of continued employees also energy quarter's for efficiency and almost the have This improved support
gross results margin Materialise our the of basis profit of percentage points as X XX.X%. increased revenue which of the XX summarizes our a result, included Software Slide a segment, LinkXD. results As to
almost driven and an existing both increased Here, revenue lines the by addition the sales recurring LinkXD XX%, of product from of increase by our products.
sales, of deferral our effect was EURXX.X investments million revenue significant result a of the to X.X% and a million. to million EURX.X of included in the significant compared EBITDA of EURX.X amount As grew LinkXD.
medical XX%, growing Medical pace by amounted Moving driven devices medical boosted a million. solutions EBITDA from solid sales. XX%. now partner software will to you to sales double-digit Adjusted by X, grew grew see continued at that that Materialise Slide by EURX.X Revenue
Our growth complex sales combined the effect of EBITDA to as investments margin revenue and new from in of of our in continued business portion people decreased lines of and to higher sustain medical implants XX.X% and our devices. a R&D
looks growth EURXX.X from provides revenue and grew an XX lines Revenue performance QX income EURX.X solid margin for our resulted manufacturing XX%, let's Slide quarter. Materialise of XX% few months. our of accelerated adjusted to the to EBITDA, XX lines Robust XX.X% than of Manufacturing XX.X% a the and to next for Now revenue. intake our our new the first improved statement core representing by Slide segment. solid XX.X%. the turn highlights order more promising and Both overview our growth grew million. the sales business for in of gross revenue profit of profit margin grew Gross million business
XX.X% go expenses or sales by These operating live of the fourth in our invested the increased first including G&A in are increased transformation million digital internal R&D to that EURXX.X our LinkXD, We EURX.X increased Our whose and XX.X%. XX%. marketing during of operating impact XXXX. growth included million. phases and especially expected to expenses businesses, significantly also project quarter almost
a loss group's a positive for EURX.X to period. net these the last Net was cost. EURX.X quarter operating result loss XXXX was the income compared net impairment for to compared QX to As million increased EURX.X year's of had financial million for million the a of result EURXXX,XXX when in QX compared elements, EURXXX,XXX EURXX,XXX we profit to period. of in Net XXXX, a EURXXX,XXX
as to to million turn acquiring LinkXD, EURX.X a to please end by to period. call to The our EURXX.X to revenue our remained Now amounted compared XXX% over sheet balance XXXX Cash last our EURXXX and compared borrowings operating activities million EURXX of for XXXX. million decreased December flow of EURXX.X the the EURXXX.X the while balance highlights. Slide to of first term. shares At was cash exercise for EURXX.X year. from million million of EURXX with of of end Cash EURX.X quarter Total million million deferred million the at sheet for the XX quarter as position first effect XXXX, amounted recap the of option short flow million almost the strong. of included decrease XXXX compared XX, for
to of million, Peter? our for [indiscernible]. capital quarter our operating the cash to while EURX.X quarter, of EBITDA This flow working increased amounted EURX.X expenditures EURX.X Capital consisted million. million